Covered recipient · General Payments record
ANTHONY CAREY PODBIELSKI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$629.75
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $297.87 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $61.69 | 2 |
| Novo Nordisk AS | $58.83 | 4 |
| PFIZER INC. | $49.25 | 3 |
| Lilly USA, LLC | $32.09 | 2 |
| Inspire Medical Systems, Inc. | $28.39 | 2 |
| Astellas Pharma US Inc | $26.78 | 1 |
| DEXCOM, INC. | $20.86 | 1 |
| Amneal Pharmaceuticals LLC | $19.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.92 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108025844 | CMS |
| ABBVIE INC. | $27.77 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108025846 | CMS |
| Amneal Pharmaceuticals LLC | $19.98 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139215168 | CMS |
| Astellas Pharma US Inc | $26.78 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139502697 | CMS |
| Dexcom, Inc. | $20.86 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153349662 | CMS |
| Inspire Medical Systems, Inc. | $14.58 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148165705 | CMS |
| Inspire Medical Systems, Inc. | $13.81 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148165707 | CMS |
| Lilly USA, LLC | $16.18 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135535844 | CMS |
| Lilly USA, LLC | $15.91 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135516444 | CMS |
| Novo Nordisk Inc | $14.59 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100378843 | CMS |
| Novo Nordisk Inc | $14.51 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100352306 | CMS |
| Novo Nordisk Inc | $13.14 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100353042 | CMS |
| Novo Nordisk Inc | $16.59 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100655119 | CMS |
| PFIZER INC. | $20.37 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131561648 | CMS |
| PFIZER INC. | $15.37 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131625895 | CMS |
| PFIZER INC. | $13.51 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131889161 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.